Stocks and Investing Stocks and Investing
Wed, August 9, 2023

Gena Wang Maintained (BEAM) at Hold with Decreased Target to $35 on, Aug 9th, 2023


Published on 2024-10-28 05:44:47 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Decreased Target from $41 to $35 on, Aug 9th, 2023.

Gena has made no other calls on BEAM in the last 4 months.



There is 1 other peer that has a rating on BEAM. Out of the 1 peers that are also analyzing BEAM, all agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $42 on, Thursday, May 11th, 2023

Contributing Sources